Sputnik 5 Vaccine For Use In India To Be Discussed At Key Meet Today

Sputnik 5 Vaccine For Use In India To Be Discussed At Key Meet Today

Newsdesk |
April 12, 2021

The use of Russia's Covid vaccine Sputnik-V in India will be discussed by a committee of experts today in the middle of a record spike in virus cases in the country. The vaccine, manufactured in India by Dr Reddy's, has an effectiveness of 91.6 per cent, highest after the Moderna and Pfizer shots.

New Delhi, 12 April 2021

As per news report of NDTV, The Subject Expert Committee (SEC) of the Indian drug regulator will meet later today to consider granting emergency use approval to Sputnik V. In its last meeting on April 1, the committee had asked Dr Reddy's to submit data on how the shot activates the body's immune response against the coronavirus. The panel had also asked unblinded data of all the serious adverse events - meaning that subjects would know which shot was administered to them, the vaccine or a placebo. A comparative analysis of phase III data generated on the Indian and Russian studies at various times was also sought. Dr Reddy's had applied on February 19 for emergency use of Sputnik-V, which is in Phase 3 of clinical trials in India, the UAE, Venezuela and Belarus.

Source -NDTV


If you like the story and if you wish more such stories, support our effort Make a donation.


If you believe investigative journalism is essential to making democracy functional and accountable support us. »